Generic placeholder image

Current Molecular Imaging (Discontinued)


ISSN (Print): 2211-5552
ISSN (Online): 2211-5544

In vitro Evaluation of Gadolinium-Silica Mesoporous Nanoparticles- Monoclonal Antibody: Potential Nanoprobe for Prostate Cancer Cell Imaging

Author(s): Negar Ghalandarlaki, Noorahmad Latifi, Mehdi Mirzaei, Mohammad T. Joghatei, Sepideh Safari, Khadijeh Ashtari and Bita Mehravi

Volume 4, Issue 1, 2015

Page: [35 - 42] Pages: 8

DOI: 10.2174/2211555204666151003003204

Price: $65


Purpose: The unambiguous prostate cancer diagnosis is of high global interest. Magnetic Resonance Imaging (MRI) is a low invasive modality in early stages of tumor diagnosis, especially for cancer detection. The study aim is to synthesize Gd3+ based silica mesoporous nanosphere conjugated with Monoclonal Antibody (Mab C595) and evaluate its ability as nanoprobe for prostate cancer cells detection.

Method: Here, a nanoprobe, specifically recognizing in vivo MUC-1 antigen in prostate cancer cells, was synthesized and evaluated. The in vitro studies included cell toxicity, cell binding and immune reactivity assay. MR imaging parameters of this nanoprobe were investigated by MRI.

Results: Results showed that this nanoprobe is a selective MUC-1 detector, without any significant cell toxicity.

Conclusion: This study confirmed that this nanoprobe is potentially a selective prostate molecular imaging agent for cancer cell detection.

Keywords: Mesoporous silica nanosphere, MR imaging, monoclonal antibody C595, MUC-1, prostate cancer detection.

Graphical Abstract

Rights & Permissions Print Export Cite as
© 2023 Bentham Science Publishers | Privacy Policy